Publications by authors named "Joshua Ruff"

Background: Heightened immune activation and exhaustion drive HIV disease progression and comorbidities. Vitamin D has pleiotropic immunomodulatory effects, but little is known about the effects of supplementation in HIV. Our study investigates changes in immune activation and exhaustion markers after 12 months of supplementation in virologically suppressed HIV-infected youth with vitamin D insufficiency.

View Article and Find Full Text PDF

Background: Low bone mineral density (BMD) is a significant comorbidity in HIV. However, studies evaluating vitamin D supplementation on bone health in this population are limited. This study investigates changes in bone health parameters after 12 months of supplementation in HIV-infected youth with vitamin D insufficiency.

View Article and Find Full Text PDF

Background: HIV-infected individuals are at increased risk of neurocognitive impairment compared to the general population. Studies suggest that, despite combination antiretroviral therapy (cART), HIV infection causes immune activation which results in neural damage; however, few data exist in HIV-infected youth.

Methods: HIV-infected youth 8-26-years-old on cART with virological suppression were prospectively enrolled along with healthy controls.

View Article and Find Full Text PDF

Children and young adults infected with HIV are at elevated risk for cardiovascular disease (CVD). However, scarce data exist on the utility of non-invasive methods to diagnose subclinical CVD, such as pulse wave velocity (PWV), a non-invasive measure of arterial stiffness. The objectives of this study were to assess the relationship of carotid-femoral PWV with subclinical atherosclerosis measured by carotid intima-media thickness (IMT), compare measurements to healthy controls, and evaluate variables associated with PWV in HIV-infected youth.

View Article and Find Full Text PDF
Article Synopsis
  • Vitamin D insufficiency is common in HIV-infected patients, and a study investigated the effects of cholecalciferol supplementation on vitamin D levels in youth on antiretroviral therapy (ART).
  • After 6 months, a significant increase in 25-hydroxycholecalciferol (25(OH)D) levels was observed, with 82% of those receiving supplementation reaching adequate levels compared to 55% in the control group.
  • The study concluded that high-dose vitamin D supplementation effectively improves vitamin D status in HIV-infected youth, showing similar results to healthy uninfected individuals.
View Article and Find Full Text PDF

Amino acids play critical roles in metabolism, cell function, body composition and immunity, but little data on plasma amino acid concentrations in HIV are available. We evaluated plasma amino acid concentrations and associations with CD4 counts and inflammatory biomarkers in HIV-infected youth. HIV-infected subjects with a high (≥500 cells/mm) and low (<500 cells/mm) current CD4 T cell counts were compared to one another and to a matched healthy control group.

View Article and Find Full Text PDF